Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05744193 · ClinicalTrials.gov registry record · NA
Feeding Study in VLBW Premature Infants
A NA study, sponsored by Mead Johnson Nutrition.
- Terminated
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT05744193: Clinical Trial NA study, sponsored by Mead Johnson Nutrition.
NCT05744193 is a NA study that was terminated before completion, run by Mead Johnson Nutrition. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05744193, a NA study, was terminated before completion, sponsored by Mead Johnson Nutrition.
- TERMINATED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
A multi-center, single-blind, randomized, controlled, parallel-designed, prospective trial to compare growth between preterm infants fed one of three study human milk fortifiers added to human milk
Primary Outcome
grams/kg/day
Interventions
- OTHER Exempt Infant Formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2023-07-10 |
| Est. Completion | 2024-05-31 |
| Phase | NA |
Why NCT05744193 stopped before completion
NCT05744193 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Exempt Infant Formula is the first listed.
NCT05744193 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05744193 about?
NCT05744193 is a clinical study titled "Feeding Study in VLBW Premature Infants". A multi-center, single-blind, randomized, controlled, parallel-designed, prospective trial to compare growth between preterm infants fed one of three study human milk fortifiers added to human milk
What is the current status of trial NCT05744193?
This trial is currently terminated. It is a NA study. The enrollment target is 22 participants. The study started on 2023-07-10. Estimated completion is 2024-05-31.
What interventions are being tested in trial NCT05744193?
The interventions under investigation include: Exempt Infant Formula (OTHER).
Who is sponsoring clinical trial NCT05744193?
This trial is sponsored by Mead Johnson Nutrition, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05744193's enrollment target sits among peer trials
22 1756th of 2000 higher than 239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI